Our team advises a pharmaceutical company on its investment in a new manufacturing and R&D site in Sofia

On December 21, 2022, a Class A investment certificate was awarded to Adipharm EAD for its project for the construction of a production and R&D complex.

Adipharm EAD has been on the market for 25 years – currently, its range of products includes more than 100 medicines and food supplements distributed in 36 countries worldwide. Over the past few years, the company has continued to develop successfully despite the challenges through far-sighted management of its production and scientific activities.

The project for the new production and research & development site aims to expand the company’s capacity to produce and create new and modern pharmaceutical products. The amount of the investment is worth 3.6 million euros and includes equipping the new site with modern and innovative machinery and equipment, as well as acquiring know-how for the development of new medicinal products and food additives.

The team of GPCo & Co. consults all aspects of the development and implementation of the project, including optimization of the investment through the support measures provided for in the Investment Promotion Act. The investment certificate provides key advantages to investors such as express administrative procedures and support by the team of the Invest Bulgaria Agency in dealing with state and municipal administration; financial support for professional training of newly employed staff and for payment of social charges and taxes. Class A investment certificate is one of the highest class that a private investor can obtain and requires a certain minimum of the investment. In addition to the standard support, it allows also for financial aid in building infrastructure when it is necessary for the project.